Skip to main content
Erschienen in: Pediatric Surgery International 1/2023

01.12.2023 | Original Article

Prednisolone administration monitored by postoperative stool color achieves high jaundice clearance after laparoscopic portoenterostomy for biliary atresia

verfasst von: Masahiro Takeda, Takafumi Tsukui, Joel Cazares, Koichi Tsuboi, Takanori Ochi, Soichi Shibuya, Hiroyuki Koga, Geoffrey J. Lane, Atsuyuki Yamataka

Erschienen in: Pediatric Surgery International | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Stool color (SC) for monitoring prednisolone use in biliary atresia (BA) patients after laparoscopic portoenterostomy (LPE) was reviewed.

Methods

Subjects were 47 post-LPE BA patients given a reducing dose course of intravenous prednisolone. The course started at 4 mg/kg/day and gradually reduced, ultimately reaching a final total dose (TD) of 31.5 mg/kg. Normal SC indicated a course could progress until finished and was repeated until jaundice clearance (JC) was achieved. Abnormal SC persisting for two consecutive courses was the absolute indication for redo or liver transplantation (LTx).

Results

JC was achieved in 38/47 (80.9%) LPE cases and 4/6 redos to give an overall JC rate (JCR) of 42/47 (89.4%). Outcomes after one course (n = 5; JCR: 80.0%; median TD: 30.0 mg/kg, interquartile range [IQR: 26.0–31.5]), two courses (n = 10; JCR: 90.0%; median TD: 62.5 mg/kg [IQR: 60.8–66.0]), three courses (n = 13; JCR: 92.3%; median TD: 90.0 mg/kg [IQR: 86.0–90.0]), four courses (n = 10; JCR: 80.0%; median TD: 120.0 mg/kg [IQR: 116.7–123.3]), five courses (n = 7; JCR: 100%; median TD: 156.0 mg/kg [IQR: 154.3–157.5]), six courses (n = 1; JCR: 100%; TD: 189.0 mg/kg), ten courses (n = 1; JCR: 100%; TD: 308 mg/kg).

Conclusion

Indications for repeat prednisolone and timing of redo/LTx based on SC monitoring appeared effective based on high JCR and successful redo/LTx.

Levels of evidence

III.
Literatur
1.
Zurück zum Zitat Kasai M, Suzuki S (1959) A new operation for non-correctable biliary atresia: hepatic portoenterostomy. Shujutu 13:733 Kasai M, Suzuki S (1959) A new operation for non-correctable biliary atresia: hepatic portoenterostomy. Shujutu 13:733
2.
Zurück zum Zitat Scottoni F, Davenport M (2020) Biliary atresia: potential for a new decade. Semin Pediatr Surg 29:150940CrossRefPubMed Scottoni F, Davenport M (2020) Biliary atresia: potential for a new decade. Semin Pediatr Surg 29:150940CrossRefPubMed
3.
Zurück zum Zitat Chen Y, Nah SA, Chiang L, Krishnaswamy G, Low Y (2015) Postoperative steroid therapy for biliary atresia: systematic review and meta-analysis. J Pediatr Surg 50:1590–1594CrossRefPubMed Chen Y, Nah SA, Chiang L, Krishnaswamy G, Low Y (2015) Postoperative steroid therapy for biliary atresia: systematic review and meta-analysis. J Pediatr Surg 50:1590–1594CrossRefPubMed
5.
Zurück zum Zitat Ando H, Inomata Y, Iwanaka T, Kuroda T, Nio M, Matsui A et al (2021) Clinical practice guidelines for biliary atresia in Japan: a secondary publication of the abbreviated version translated into English. J Hepatobiliary Pancreat Sci 28:55–61CrossRefPubMed Ando H, Inomata Y, Iwanaka T, Kuroda T, Nio M, Matsui A et al (2021) Clinical practice guidelines for biliary atresia in Japan: a secondary publication of the abbreviated version translated into English. J Hepatobiliary Pancreat Sci 28:55–61CrossRefPubMed
6.
Zurück zum Zitat Kobayashi H, Yamataka A, Koga H, Okazaki T, Tamura T, Urao M et al (2005) Optimum prednisolone usage in patients with biliary atresia postportoenterostomy. J Pediatr Surg 40:327–330CrossRefPubMed Kobayashi H, Yamataka A, Koga H, Okazaki T, Tamura T, Urao M et al (2005) Optimum prednisolone usage in patients with biliary atresia postportoenterostomy. J Pediatr Surg 40:327–330CrossRefPubMed
7.
Zurück zum Zitat Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458CrossRefPubMed Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458CrossRefPubMed
8.
Zurück zum Zitat Davenport M, Stringer MD, Tizzard SA, McClean P, Mieli-Vergani G, Hadzic N (2007) Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology 46:1821–1827CrossRefPubMed Davenport M, Stringer MD, Tizzard SA, McClean P, Mieli-Vergani G, Hadzic N (2007) Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology 46:1821–1827CrossRefPubMed
9.
Zurück zum Zitat Bezerra JA, Spino C, Magee JC, Shneider BL, Rosenthal P, Wang KS et al (2014) Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA 311:1750–1759CrossRefPubMedPubMedCentral Bezerra JA, Spino C, Magee JC, Shneider BL, Rosenthal P, Wang KS et al (2014) Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA 311:1750–1759CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Nio M, Muraji T, Society JBA (2013) Multicenter randomized trial of postoperative corticosteroid therapy for biliary atresia. Pediatr Surg Int 29:1091–1095CrossRefPubMed Nio M, Muraji T, Society JBA (2013) Multicenter randomized trial of postoperative corticosteroid therapy for biliary atresia. Pediatr Surg Int 29:1091–1095CrossRefPubMed
11.
Zurück zum Zitat Tyraskis A, Davenport M (2016) Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy. Pediatr Surg Int 32:193–200CrossRefPubMed Tyraskis A, Davenport M (2016) Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy. Pediatr Surg Int 32:193–200CrossRefPubMed
12.
Zurück zum Zitat Alonso EM, Ye W, Hawthorne K, Venkat V, Loomes KM, Mack CL et al (2018) Impact of steroid therapy on early growth in infants with biliary atresia: the multicenter steroids in biliary atresia randomized trial. J Pediatr 202:179–85.e4CrossRefPubMedPubMedCentral Alonso EM, Ye W, Hawthorne K, Venkat V, Loomes KM, Mack CL et al (2018) Impact of steroid therapy on early growth in infants with biliary atresia: the multicenter steroids in biliary atresia randomized trial. J Pediatr 202:179–85.e4CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Cheng K, Molleston JP, Bennett WE (2020) Cholangitis in patients with biliary atresia receiving hepatoportoenterostomy: a national database study. J Pediatr Gastroenterol Nutr 71:452–458CrossRefPubMed Cheng K, Molleston JP, Bennett WE (2020) Cholangitis in patients with biliary atresia receiving hepatoportoenterostomy: a national database study. J Pediatr Gastroenterol Nutr 71:452–458CrossRefPubMed
14.
Zurück zum Zitat Lu X, Jiang J, Shen Z, Chen G, Wu Y, Xiao X et al (2022) Effect of adjuvant steroid therapy in type 3 biliary atresia: a single-center, open-label, randomized controlled trial. Ann Surg 277:e1200–e1207CrossRefPubMed Lu X, Jiang J, Shen Z, Chen G, Wu Y, Xiao X et al (2022) Effect of adjuvant steroid therapy in type 3 biliary atresia: a single-center, open-label, randomized controlled trial. Ann Surg 277:e1200–e1207CrossRefPubMed
15.
Zurück zum Zitat Ohi R, Hanamatsu M, Mochizuki I, Ohkohchi N, Kasai M (1985) Reoperation in patients with biliary atresia. J Pediatr Surg 20:256–259CrossRefPubMed Ohi R, Hanamatsu M, Mochizuki I, Ohkohchi N, Kasai M (1985) Reoperation in patients with biliary atresia. J Pediatr Surg 20:256–259CrossRefPubMed
16.
Zurück zum Zitat Lilly JR, Karrer FM, Hall RJ, Stellin GP, Vasquez-Estevez JJ, Greenholz SK et al (1989) The surgery of biliary atresia. Ann Surg 210:289–294 (discussion 94-6)CrossRefPubMedPubMedCentral Lilly JR, Karrer FM, Hall RJ, Stellin GP, Vasquez-Estevez JJ, Greenholz SK et al (1989) The surgery of biliary atresia. Ann Surg 210:289–294 (discussion 94-6)CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Nio M, Sasaki H, Tanaka H, Okamura A (2013) Redo surgery for biliary atresia. Pediatr Surg Int 29:989–993CrossRefPubMed Nio M, Sasaki H, Tanaka H, Okamura A (2013) Redo surgery for biliary atresia. Pediatr Surg Int 29:989–993CrossRefPubMed
Metadaten
Titel
Prednisolone administration monitored by postoperative stool color achieves high jaundice clearance after laparoscopic portoenterostomy for biliary atresia
verfasst von
Masahiro Takeda
Takafumi Tsukui
Joel Cazares
Koichi Tsuboi
Takanori Ochi
Soichi Shibuya
Hiroyuki Koga
Geoffrey J. Lane
Atsuyuki Yamataka
Publikationsdatum
01.12.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Surgery International / Ausgabe 1/2023
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-023-05580-1

Weitere Artikel der Ausgabe 1/2023

Pediatric Surgery International 1/2023 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.